Cd79a-2A-Cre
品系全名
C57BL/6JSmo-Cd79aem(2A-Cre)Smoc
目录号
NM-KI-220089
品系状态
精子冻存
基因信息
基因名
CD79a
品系描述
验证数据

Fig1. Cre mediated recombination in kidney of Cd79aCre/+; Rosa26tdTomato/+ mouse.

Fig2. Detection of tdTomato(red) in various tissues of Cd79aCre/+; Rosa26tdTomato/+ mouse.
Tissues expressing tdTomato: stomach, salivary gland, adrenal gland, kidney, pancreas, large intestine, small intestine, spleen, genitalia, thymus, pituitary gland. Low expression in tissues: brain, lung, skin. Non-expressing tissues: heart, eye, liver, brown fat, spinal cord, muscle. (9.6-weeks old, female) (For more detailed information please contact our technical advisor.)

Fig3. Detection of tdTomato expression in CD19+CD79a+ cells of spleen and peripheral blood by FACS.
Leukocytes were collected from HE Cd79a-2A-Cre mice (male, 16 weeks old) and HE/HE R26-CAG-LSL-tdTomato/Cd79a-2A-Cre mice (male, 4 weeks old), and analyzed by flow cytometry with anti-mCD79a.
Abbr. HE, Heterozygote; WT, wild type.

Fig4. Detection of tdTomato expression in CD19- cells of spleen and peripheral blood by FACS.
Leukocytes were collected from HE Cd79a-2A-Cre mice (male, 16 weeks old) and HE/HE R26-CAG-LSL-tdTomato/Cd79a-2A-Cre mice (male, 4 weeks old), and analyzed by flow cytometry with anti-mCD79a.
Abbr. HE, Heterozygote; WT, wild type.
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop:Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
